简介:摘要:目的 探讨针对白色念珠菌性阴道炎育龄期患者运用整体护理的效果。方法 选择78例白色念珠菌性阴道炎育龄期患者,按照机选原则分组,运用整体护理(综合组)和常规护理(参照组),各39例,对比两组患者的抑郁、焦虑评分和生活质量评分的变化。结果 两组患者年龄、病程在统计学上无显著差异(P>0.05)。综合组患者的抑郁、焦虑评分较治疗前明显降低,且低于参照组(P=0.003)。综合组患者护理后的生活质量评分明显提高,高于参照组(P=0.003)。综合组患者的满意度(97.44%)明显高于参照组(76.92%),差异具有统计学意义(P=0.003)。结论 对白色念珠菌性阴道炎育龄期患者运用整体护理,可以有效降低患者的抑郁、焦虑评分,提高生活质量评分,提高患者的满意度,其效果优于常规护理。
简介:【摘要】目的 对比观察在临床病理技术质量控制中,免疫组化染色的影响。方法 将本院2020年7月-2021年7月间收治的患者资料进行整理,从中抽取74例进行分析,根据不同的染色方式均分2组,其中采取常规染色的37例记作参照组,另采取免疫组化染色的37例记作研究组,对比在不同方案下切片的结果及诊断结果,观察不同染色技术的应用价值。结果 于研究组染色方案下切片有更高的优良率,对比有统计差异(P<0.05)。于研究组方案下诊断的准确性更高,对比差异明显(P<0.05)。结论 在临床病理技术质量控制中,免疫组化染色方案的应用,能够显著的对切片的优良率起到提升的效果,让临床对于患者的诊断更加准确,后续治疗方案更加科学,适合应用。
简介: [摘要 ] 目的 探讨美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎的疗效及其对炎性因子的影响。 方法 选取 2018年 1月~ 2020年 1月我院收治的溃疡性结肠炎患者 80例,随机分为两组,每组各 40例,两组患者均予常规对症治疗,同时两组均予美沙拉嗪缓释颗粒,观察组同时加用双歧三联活菌胶囊,治疗后比较两组患者治疗后的临床疗效,以及两组患者治疗前后 TNF-α、 IL-10水平的变化情况及两组患者治疗前后的临床症状积分变化情况。结果 观察组治疗后的总有效率为 95.00%,显著高于对照组的总有效率 70.00%,两组疗效比较差异具有显著性( P<0.05)。治疗后,两组患者的炎性因子 TNF-α、 IL-10水平较治疗前显著降低( P<0.05)。且观察组患者治疗后的 TNF-α、 IL-10水平显著低于对照组( P<0.05)。观察组患者治疗后的临床症状积分为( 2.56±0.85)分,与治疗前及对照组比较,差异有统计学意义( P<0.05)。 结论 美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎疗效确切,且可以抑制炎症反应,值得临床推广和应用。 [关键词 ] 溃疡性结肠炎 ;美沙拉嗪 ;双歧三联活菌 ;炎性因子 [Abstract] Objective To investigate the efficacy of mesalazine combined with Bifid Triple Viable Bacteria in the treatment of ulcerative colitis and its influence on inflammatory factors. method Methods: 80 patients with ulcerative colitis in our hospital from January 2018 to January 2020 were selected and randomly divided into two groups, 40 cases in each group. Both groups were given conventional symptomatic treatment, while the two groups were given mesalazine sustained-release granules. The observation group was also given Bifid Triple Viable capsules. After treatment, the clinical efficacy of the two groups of patients after treatment, as well as TNF - α, IL-10 water before and after treatment, were compared between the two groups The changes of the two groups of patients before and after treatment of clinical symptoms integral changes. Results the total effective rate of the observation group was 95.00%, which was significantly higher than that of the control group (70.00%). There was a significant difference between the two groups (P < 0.05). After treatment, the levels of inflammatory factors TNF - α and IL-10 in the two groups were significantly lower than those before treatment (P < 0.05). The levels of TNF - α and IL-10 in the observation group were significantly lower than those in the control group (P < 0.05). The clinical symptom score of the observation group after treatment was (2.56 ± 0.85), and the difference was statistically significant (P < 0.05). Conclusion mesalazine combined with Bifid Triple Viable Bacteria is effective in the treatment of ulcerative colitis, and can inhibit inflammatory reaction, which is worthy of clinical promotion and application.